The global Molecular Diagnostics in Point of Care market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
We have surveyed the Molecular Diagnostics in Point of Care companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostics in Point of Care, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostics in Point of Care. This report contains market size and forecasts of Molecular Diagnostics in Point of Care in global, including the following market information:
Global Molecular Diagnostics in Point of Care market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Molecular Diagnostics in Point of Care companies in 2024 (%)
Total Market by Segment:
Global Molecular Diagnostics in Point of Care market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Molecular Diagnostics in Point of Care market segment percentages, by Type, 2024 (%)
Polymerase Chain Reaction
In Situ Hybridization
Gene Chips
Next Generation Sequencing
Global Molecular Diagnostics in Point of Care market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Molecular Diagnostics in Point of Care market segment percentages, by Application, 2024 (%)
Hospitals and Clinics
Independent Clinical Laboratories
Global Molecular Diagnostics in Point of Care market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Molecular Diagnostics in Point of Care market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Molecular Diagnostics in Point of Care revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Molecular Diagnostics in Point of Care revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Accelerate Diagnostics
Ador Diagnostics
Beckman Coulter
Becton, Dickinson and Company
Binx Health
Biocartis
bioM�rieux
Bio-Rad Laboratories
Bosch Healthcare Solutions
Curetis
Eurofins Scientific
Genetic Signatures
Grifols
Hibergene Diagnostics
Lumos Diagnostics
Roche
Siemens
Thermo Fisher Scientific
Outline of Major Chapters:
Chapter 1: Introduces the definition of Molecular Diagnostics in Point of Care, market overview.
Chapter 2: Global Molecular Diagnostics in Point of Care market size in revenue.
Chapter 3: Detailed analysis of Molecular Diagnostics in Point of Care company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Molecular Diagnostics in Point of Care in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Molecular Diagnostics in Point of Care Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Molecular Diagnostics in Point of Care Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Diagnostics in Point of Care Overall Market Size
2.1 Global Molecular Diagnostics in Point of Care Market Size: 2024 VS 2032
2.2 Global Molecular Diagnostics in Point of Care Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Molecular Diagnostics in Point of Care Players in Global Market
3.2 Top Global Molecular Diagnostics in Point of Care Companies Ranked by Revenue
3.3 Global Molecular Diagnostics in Point of Care Revenue by Companies
3.4 Top 3 and Top 5 Molecular Diagnostics in Point of Care Companies in Global Market, by Revenue in 2024
3.5 Global Companies Molecular Diagnostics in Point of Care Product Type
3.6 Tier 1, Tier 2, and Tier 3 Molecular Diagnostics in Point of Care Players in Global Market
3.6.1 List of Global Tier 1 Molecular Diagnostics in Point of Care Companies
3.6.2 List of Global Tier 2 and Tier 3 Molecular Diagnostics in Point of Care Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Molecular Diagnostics in Point of Care Market Size Markets, 2024 & 2032
4.1.2 Polymerase Chain Reaction
4.1.3 In Situ Hybridization
4.1.4 Gene Chips
4.1.5 Next Generation Sequencing
4.2 Segmentation by Type - Global Molecular Diagnostics in Point of Care Revenue & Forecasts
4.2.1 Segmentation by Type - Global Molecular Diagnostics in Point of Care Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Molecular Diagnostics in Point of Care Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Molecular Diagnostics in Point of Care Market Size, 2024 & 2032
5.1.2 Hospitals and Clinics
5.1.3 Independent Clinical Laboratories
5.2 Segmentation by Application - Global Molecular Diagnostics in Point of Care Revenue & Forecasts
5.2.1 Segmentation by Application - Global Molecular Diagnostics in Point of Care Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Molecular Diagnostics in Point of Care Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Molecular Diagnostics in Point of Care Market Size, 2024 & 2032
6.2 By Region - Global Molecular Diagnostics in Point of Care Revenue & Forecasts
6.2.1 By Region - Global Molecular Diagnostics in Point of Care Revenue, 2020-2025
6.2.2 By Region - Global Molecular Diagnostics in Point of Care Revenue, 2026-2032
6.2.3 By Region - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Molecular Diagnostics in Point of Care Revenue, 2020-2032
6.3.2 United States Molecular Diagnostics in Point of Care Market Size, 2020-2032
6.3.3 Canada Molecular Diagnostics in Point of Care Market Size, 2020-2032
6.3.4 Mexico Molecular Diagnostics in Point of Care Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Molecular Diagnostics in Point of Care Revenue, 2020-2032
6.4.2 Germany Molecular Diagnostics in Point of Care Market Size, 2020-2032
6.4.3 France Molecular Diagnostics in Point of Care Market Size, 2020-2032
6.4.4 U.K. Molecular Diagnostics in Point of Care Market Size, 2020-2032
6.4.5 Italy Molecular Diagnostics in Point of Care Market Size, 2020-2032
6.4.6 Russia Molecular Diagnostics in Point of Care Market Size, 2020-2032
6.4.7 Nordic Countries Molecular Diagnostics in Point of Care Market Size, 2020-2032
6.4.8 Benelux Molecular Diagnostics in Point of Care Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Molecular Diagnostics in Point of Care Revenue, 2020-2032
6.5.2 China Molecular Diagnostics in Point of Care Market Size, 2020-2032
6.5.3 Japan Molecular Diagnostics in Point of Care Market Size, 2020-2032
6.5.4 South Korea Molecular Diagnostics in Point of Care Market Size, 2020-2032
6.5.5 Southeast Asia Molecular Diagnostics in Point of Care Market Size, 2020-2032
6.5.6 India Molecular Diagnostics in Point of Care Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Molecular Diagnostics in Point of Care Revenue, 2020-2032
6.6.2 Brazil Molecular Diagnostics in Point of Care Market Size, 2020-2032
6.6.3 Argentina Molecular Diagnostics in Point of Care Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Molecular Diagnostics in Point of Care Revenue, 2020-2032
6.7.2 Turkey Molecular Diagnostics in Point of Care Market Size, 2020-2032
6.7.3 Israel Molecular Diagnostics in Point of Care Market Size, 2020-2032
6.7.4 Saudi Arabia Molecular Diagnostics in Point of Care Market Size, 2020-2032
6.7.5 UAE Molecular Diagnostics in Point of Care Market Size, 2020-2032
7 Companies Profiles
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Molecular Diagnostics in Point of Care Major Product Offerings
7.1.4 Abbott Molecular Diagnostics in Point of Care Revenue in Global Market (2020-2025)
7.1.5 Abbott Key News & Latest Developments
7.2 Accelerate Diagnostics
7.2.1 Accelerate Diagnostics Corporate Summary
7.2.2 Accelerate Diagnostics Business Overview
7.2.3 Accelerate Diagnostics Molecular Diagnostics in Point of Care Major Product Offerings
7.2.4 Accelerate Diagnostics Molecular Diagnostics in Point of Care Revenue in Global Market (2020-2025)
7.2.5 Accelerate Diagnostics Key News & Latest Developments
7.3 Ador Diagnostics
7.3.1 Ador Diagnostics Corporate Summary
7.3.2 Ador Diagnostics Business Overview
7.3.3 Ador Diagnostics Molecular Diagnostics in Point of Care Major Product Offerings
7.3.4 Ador Diagnostics Molecular Diagnostics in Point of Care Revenue in Global Market (2020-2025)
7.3.5 Ador Diagnostics Key News & Latest Developments
7.4 Beckman Coulter
7.4.1 Beckman Coulter Corporate Summary
7.4.2 Beckman Coulter Business Overview
7.4.3 Beckman Coulter Molecular Diagnostics in Point of Care Major Product Offerings
7.4.4 Beckman Coulter Molecular Diagnostics in Point of Care Revenue in Global Market (2020-2025)
7.4.5 Beckman Coulter Key News & Latest Developments
7.5 Becton, Dickinson and Company
7.5.1 Becton, Dickinson and Company Corporate Summary
7.5.2 Becton, Dickinson and Company Business Overview
7.5.3 Becton, Dickinson and Company Molecular Diagnostics in Point of Care Major Product Offerings
7.5.4 Becton, Dickinson and Company Molecular Diagnostics in Point of Care Revenue in Global Market (2020-2025)
7.5.5 Becton, Dickinson and Company Key News & Latest Developments
7.6 Binx Health
7.6.1 Binx Health Corporate Summary
7.6.2 Binx Health Business Overview
7.6.3 Binx Health Molecular Diagnostics in Point of Care Major Product Offerings
7.6.4 Binx Health Molecular Diagnostics in Point of Care Revenue in Global Market (2020-2025)
7.6.5 Binx Health Key News & Latest Developments
7.7 Biocartis
7.7.1 Biocartis Corporate Summary
7.7.2 Biocartis Business Overview
7.7.3 Biocartis Molecular Diagnostics in Point of Care Major Product Offerings
7.7.4 Biocartis Molecular Diagnostics in Point of Care Revenue in Global Market (2020-2025)
7.7.5 Biocartis Key News & Latest Developments
7.8 bioM�rieux
7.8.1 bioM�rieux Corporate Summary
7.8.2 bioM�rieux Business Overview
7.8.3 bioM�rieux Molecular Diagnostics in Point of Care Major Product Offerings
7.8.4 bioM�rieux Molecular Diagnostics in Point of Care Revenue in Global Market (2020-2025)
7.8.5 bioM�rieux Key News & Latest Developments
7.9 Bio-Rad Laboratories
7.9.1 Bio-Rad Laboratories Corporate Summary
7.9.2 Bio-Rad Laboratories Business Overview
7.9.3 Bio-Rad Laboratories Molecular Diagnostics in Point of Care Major Product Offerings
7.9.4 Bio-Rad Laboratories Molecular Diagnostics in Point of Care Revenue in Global Market (2020-2025)
7.9.5 Bio-Rad Laboratories Key News & Latest Developments
7.10 Bosch Healthcare Solutions
7.10.1 Bosch Healthcare Solutions Corporate Summary
7.10.2 Bosch Healthcare Solutions Business Overview
7.10.3 Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Major Product Offerings
7.10.4 Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Revenue in Global Market (2020-2025)
7.10.5 Bosch Healthcare Solutions Key News & Latest Developments
7.11 Curetis
7.11.1 Curetis Corporate Summary
7.11.2 Curetis Business Overview
7.11.3 Curetis Molecular Diagnostics in Point of Care Major Product Offerings
7.11.4 Curetis Molecular Diagnostics in Point of Care Revenue in Global Market (2020-2025)
7.11.5 Curetis Key News & Latest Developments
7.12 Eurofins Scientific
7.12.1 Eurofins Scientific Corporate Summary
7.12.2 Eurofins Scientific Business Overview
7.12.3 Eurofins Scientific Molecular Diagnostics in Point of Care Major Product Offerings
7.12.4 Eurofins Scientific Molecular Diagnostics in Point of Care Revenue in Global Market (2020-2025)
7.12.5 Eurofins Scientific Key News & Latest Developments
7.13 Genetic Signatures
7.13.1 Genetic Signatures Corporate Summary
7.13.2 Genetic Signatures Business Overview
7.13.3 Genetic Signatures Molecular Diagnostics in Point of Care Major Product Offerings
7.13.4 Genetic Signatures Molecular Diagnostics in Point of Care Revenue in Global Market (2020-2025)
7.13.5 Genetic Signatures Key News & Latest Developments
7.14 Grifols
7.14.1 Grifols Corporate Summary
7.14.2 Grifols Business Overview
7.14.3 Grifols Molecular Diagnostics in Point of Care Major Product Offerings
7.14.4 Grifols Molecular Diagnostics in Point of Care Revenue in Global Market (2020-2025)
7.14.5 Grifols Key News & Latest Developments
7.15 Hibergene Diagnostics
7.15.1 Hibergene Diagnostics Corporate Summary
7.15.2 Hibergene Diagnostics Business Overview
7.15.3 Hibergene Diagnostics Molecular Diagnostics in Point of Care Major Product Offerings
7.15.4 Hibergene Diagnostics Molecular Diagnostics in Point of Care Revenue in Global Market (2020-2025)
7.15.5 Hibergene Diagnostics Key News & Latest Developments
7.16 Lumos Diagnostics
7.16.1 Lumos Diagnostics Corporate Summary
7.16.2 Lumos Diagnostics Business Overview
7.16.3 Lumos Diagnostics Molecular Diagnostics in Point of Care Major Product Offerings
7.16.4 Lumos Diagnostics Molecular Diagnostics in Point of Care Revenue in Global Market (2020-2025)
7.16.5 Lumos Diagnostics Key News & Latest Developments
7.17 Roche
7.17.1 Roche Corporate Summary
7.17.2 Roche Business Overview
7.17.3 Roche Molecular Diagnostics in Point of Care Major Product Offerings
7.17.4 Roche Molecular Diagnostics in Point of Care Revenue in Global Market (2020-2025)
7.17.5 Roche Key News & Latest Developments
7.18 Siemens
7.18.1 Siemens Corporate Summary
7.18.2 Siemens Business Overview
7.18.3 Siemens Molecular Diagnostics in Point of Care Major Product Offerings
7.18.4 Siemens Molecular Diagnostics in Point of Care Revenue in Global Market (2020-2025)
7.18.5 Siemens Key News & Latest Developments
7.19 Thermo Fisher Scientific
7.19.1 Thermo Fisher Scientific Corporate Summary
7.19.2 Thermo Fisher Scientific Business Overview
7.19.3 Thermo Fisher Scientific Molecular Diagnostics in Point of Care Major Product Offerings
7.19.4 Thermo Fisher Scientific Molecular Diagnostics in Point of Care Revenue in Global Market (2020-2025)
7.19.5 Thermo Fisher Scientific Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Molecular Diagnostics in Point of Care Market Opportunities & Trends in Global Market
Table 2. Molecular Diagnostics in Point of Care Market Drivers in Global Market
Table 3. Molecular Diagnostics in Point of Care Market Restraints in Global Market
Table 4. Key Players of Molecular Diagnostics in Point of Care in Global Market
Table 5. Top Molecular Diagnostics in Point of Care Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Molecular Diagnostics in Point of Care Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Molecular Diagnostics in Point of Care Revenue Share by Companies, 2020-2025
Table 8. Global Companies Molecular Diagnostics in Point of Care Product Type
Table 9. List of Global Tier 1 Molecular Diagnostics in Point of Care Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Molecular Diagnostics in Point of Care Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Molecular Diagnostics in Point of Care Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Molecular Diagnostics in Point of Care Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2026-2032
Table 30. Abbott Corporate Summary
Table 31. Abbott Molecular Diagnostics in Point of Care Product Offerings
Table 32. Abbott Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2020-2025)
Table 33. Abbott Key News & Latest Developments
Table 34. Accelerate Diagnostics Corporate Summary
Table 35. Accelerate Diagnostics Molecular Diagnostics in Point of Care Product Offerings
Table 36. Accelerate Diagnostics Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2020-2025)
Table 37. Accelerate Diagnostics Key News & Latest Developments
Table 38. Ador Diagnostics Corporate Summary
Table 39. Ador Diagnostics Molecular Diagnostics in Point of Care Product Offerings
Table 40. Ador Diagnostics Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2020-2025)
Table 41. Ador Diagnostics Key News & Latest Developments
Table 42. Beckman Coulter Corporate Summary
Table 43. Beckman Coulter Molecular Diagnostics in Point of Care Product Offerings
Table 44. Beckman Coulter Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2020-2025)
Table 45. Beckman Coulter Key News & Latest Developments
Table 46. Becton, Dickinson and Company Corporate Summary
Table 47. Becton, Dickinson and Company Molecular Diagnostics in Point of Care Product Offerings
Table 48. Becton, Dickinson and Company Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2020-2025)
Table 49. Becton, Dickinson and Company Key News & Latest Developments
Table 50. Binx Health Corporate Summary
Table 51. Binx Health Molecular Diagnostics in Point of Care Product Offerings
Table 52. Binx Health Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2020-2025)
Table 53. Binx Health Key News & Latest Developments
Table 54. Biocartis Corporate Summary
Table 55. Biocartis Molecular Diagnostics in Point of Care Product Offerings
Table 56. Biocartis Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2020-2025)
Table 57. Biocartis Key News & Latest Developments
Table 58. bioM�rieux Corporate Summary
Table 59. bioM�rieux Molecular Diagnostics in Point of Care Product Offerings
Table 60. bioM�rieux Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2020-2025)
Table 61. bioM�rieux Key News & Latest Developments
Table 62. Bio-Rad Laboratories Corporate Summary
Table 63. Bio-Rad Laboratories Molecular Diagnostics in Point of Care Product Offerings
Table 64. Bio-Rad Laboratories Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2020-2025)
Table 65. Bio-Rad Laboratories Key News & Latest Developments
Table 66. Bosch Healthcare Solutions Corporate Summary
Table 67. Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Product Offerings
Table 68. Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2020-2025)
Table 69. Bosch Healthcare Solutions Key News & Latest Developments
Table 70. Curetis Corporate Summary
Table 71. Curetis Molecular Diagnostics in Point of Care Product Offerings
Table 72. Curetis Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2020-2025)
Table 73. Curetis Key News & Latest Developments
Table 74. Eurofins Scientific Corporate Summary
Table 75. Eurofins Scientific Molecular Diagnostics in Point of Care Product Offerings
Table 76. Eurofins Scientific Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2020-2025)
Table 77. Eurofins Scientific Key News & Latest Developments
Table 78. Genetic Signatures Corporate Summary
Table 79. Genetic Signatures Molecular Diagnostics in Point of Care Product Offerings
Table 80. Genetic Signatures Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2020-2025)
Table 81. Genetic Signatures Key News & Latest Developments
Table 82. Grifols Corporate Summary
Table 83. Grifols Molecular Diagnostics in Point of Care Product Offerings
Table 84. Grifols Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2020-2025)
Table 85. Grifols Key News & Latest Developments
Table 86. Hibergene Diagnostics Corporate Summary
Table 87. Hibergene Diagnostics Molecular Diagnostics in Point of Care Product Offerings
Table 88. Hibergene Diagnostics Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2020-2025)
Table 89. Hibergene Diagnostics Key News & Latest Developments
Table 90. Lumos Diagnostics Corporate Summary
Table 91. Lumos Diagnostics Molecular Diagnostics in Point of Care Product Offerings
Table 92. Lumos Diagnostics Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2020-2025)
Table 93. Lumos Diagnostics Key News & Latest Developments
Table 94. Roche Corporate Summary
Table 95. Roche Molecular Diagnostics in Point of Care Product Offerings
Table 96. Roche Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2020-2025)
Table 97. Roche Key News & Latest Developments
Table 98. Siemens Corporate Summary
Table 99. Siemens Molecular Diagnostics in Point of Care Product Offerings
Table 100. Siemens Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2020-2025)
Table 101. Siemens Key News & Latest Developments
Table 102. Thermo Fisher Scientific Corporate Summary
Table 103. Thermo Fisher Scientific Molecular Diagnostics in Point of Care Product Offerings
Table 104. Thermo Fisher Scientific Molecular Diagnostics in Point of Care Revenue (US$, Mn) & (2020-2025)
Table 105. Thermo Fisher Scientific Key News & Latest Developments
List of Figures
Figure 1. Molecular Diagnostics in Point of Care Product Picture
Figure 2. Molecular Diagnostics in Point of Care Segment by Type in 2024
Figure 3. Molecular Diagnostics in Point of Care Segment by Application in 2024
Figure 4. Global Molecular Diagnostics in Point of Care Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Molecular Diagnostics in Point of Care Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Molecular Diagnostics in Point of Care Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Molecular Diagnostics in Point of Care Revenue in 2024
Figure 9. Segmentation by Type � Global Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2020-2032
Figure 13. By Region - Global Molecular Diagnostics in Point of Care Revenue Market Share, 2020-2032
Figure 14. By Country - North America Molecular Diagnostics in Point of Care Revenue Market Share, 2020-2032
Figure 15. United States Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Molecular Diagnostics in Point of Care Revenue Market Share, 2020-2032
Figure 19. Germany Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2032
Figure 20. France Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Molecular Diagnostics in Point of Care Revenue Market Share, 2020-2032
Figure 27. China Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2032
Figure 31. India Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Molecular Diagnostics in Point of Care Revenue Market Share, 2020-2032
Figure 33. Brazil Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Molecular Diagnostics in Point of Care Revenue Market Share, 2020-2032
Figure 36. Turkey Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Molecular Diagnostics in Point of Care Revenue, (US$, Mn), 2020-2032
Figure 40. Abbott Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Accelerate Diagnostics Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Ador Diagnostics Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Beckman Coulter Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Becton, Dickinson and Company Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Binx Health Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Biocartis Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. bioM�rieux Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Bio-Rad Laboratories Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. Curetis Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. Eurofins Scientific Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. Genetic Signatures Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 53. Grifols Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 54. Hibergene Diagnostics Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 55. Lumos Diagnostics Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 56. Roche Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 57. Siemens Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 58. Thermo Fisher Scientific Molecular Diagnostics in Point of Care Revenue Year Over Year Growth (US$, Mn) & (2020-2025)